Companies: 10,795·Total market cap: $144.5T

ENDRA Life Sciences Inc.

ENDRA Life Sciences Inc.

NDRANASDAQHealthcare● Active

$4.27

+$0.04(+0.95%)

Market Cap$3213734

P/E Ratio—

52W High$11.96

52W Low$2.96

Avg Volume35K

Open$4.23

Beta-0.03

股票排行：Medical - Diagnostics & Research·Healthcare·查看全部市值排行 →

ENDRA Life Sciences Inc.（NDRA）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · NDRA · 截至 Jun 9, 2026

关键指标

EPS (TTM)$-8.16Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)0.00Full revenue history

Dividend Yield不分红Dividend history

Shares Outstanding787,020Shares outstanding history

Next EarningsAug 13, 2026Est.Earnings history

探索 ENDRA Life Sciences Inc. 数据

分析师预测$— · Buy

股息不分红

盈利EPS $-8.93+12.88%

财务快照

FY 2025Revenue$0.00

202320242025

FY 2025Net Income-$7.0M▲ +38.93% YoY

202320242025

FY 2025EPS$-8.93▲ +12.88% YoY

202320242025

TTM:Revenue: $0.00Net Income: -$7.3MEPS: $-8.16View income statement →

分析师评级与目标价

Buy4 位分析师

Strong Buy

0

Buy

4

Hold

0

Sell

0

Strong Sell

0

12-Month Price Target

$—Low

$4.27Current

$—Avg Target

$—High

合计: 4 · 买入占比: 100.0%

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

ENDRA Life Sciences Inc.

$4.27+0.95%$3.2M #2

Bone Biologics Corporation

$1.25+0.10%$2.2M #3

Bio Green Med Solution, Inc.

$1.10-26.67%$2.4M #4

$0.54-0.18%$697,335 #5

DIH Holding US, Inc.

$0.00+0.00%$837 #6

GlucoTrack, Inc.

$0.54-11.06%$305,859

股票表现

1D+0.24%

1W-18.46%

1M-14.34%

3M+26.19%

YTD-6.40%

1Y+20.80%

5Y-99.99%

关于 ENDRA Life Sciences Inc.

CEOAlexander Y. Tokman

IPO DateJun 30, 2017

Employees21

CountryUS

Websiteendrainc.com

ENDRA Life Sciences Inc. specializes in advancing the capabilities of clinical diagnostic ultrasound. The company's primary development is thermo-acoustic enhanced ultrasound technology, which operate…

Medical - Diagnostics & Research HealthcareNASDAQUS

关于股票概览与关键数据

ENDRA Life Sciences Inc.（NDRA）是 Medical - Diagnostics & Research 行业的 Healthcare 类公司，于 Jun 30, 2017 在 NASDAQ 上市。截至最近交易日，NDRA 股价为 $4.27，市值约为 $3.2M。过去12个月累计回报 +20.80%，年初至今回报 -6.40%。

根据 4 位华尔街分析师，ENDRA Life Sciences Inc. 股票共识评级为Buy，12个月平均目标价为 $—。2025 财年 ENDRA Life Sciences Inc. 营收 —，净利润 -$7.0M。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。

常见问题

截至最近一个交易日，ENDRA Life Sciences Inc.（NDRA）股价为 $4.27，在 NASDAQ 上市，52周区间为 $2.96 – $11.96。

NDRA 最新股价NDRA quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 9, 2026本内容不构成投资建议